Global Opioid Use Disorder (OUD) Market Size study & Forecast, by Drug Class (Buprenorphine, Methadone, Naltrexone), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, Online Pharmacies) and Regional Analysis, 2022-2029
Global Opioid Use Disorder (OUD) Market is valued at approximately USD 2.88 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. Opioids are a class of analgesics that also relax muscles, lessen pain, and ease stress. For the treatment of moderate to severe pain, prescriptions are written for drugs including morphine, hydrocodone, oxycodone, codeine, fentanyl, methadone, and other pharmaceutical opioids. Opioid use disorder (OUD) is a long-term, relapsing brain condition defined by excessive opioid use, despite adverse effects. It is classified as a brain condition because it involves functional adjustments to brain circuits associated with motivation, stress, self-control, and decision-making and because such adjustments often last for a long period after drug use has stopped. Opioid use disorder is characterized by an intense desire to take opioids, a rise in opioid tolerance, and withdrawal symptoms following discontinuation. The market growth is primarily driven by the factors such as growing focus of government & non-government institutions, increasing incidences of chronic diseases including cancer, cardiovascular diseases and orthopedic diseases, coupled with the surge in the incidence of surgical intervention.
The rising cases of opioid addiction and related consequences are burgeoning the market demand across the globe. The National Drug Dependence Treatment Centre's (NDDTC) Magnitude of Substance Use in India reported that in February 2019, the prevalence of current opioid use is 2.06%, and approximately 0.55% of Indians are expected to require treatment for opioid use disorders (harmful use and dependence). Also, as per the Centers for Disease Control and Prevention, in 2020, there were nearly 91,799 people died from drug overdoses in the US. Age-adjusted overdose death rates increased from 21.6 per 100,000 in 2019 to 31.1 per 100,000 in 2020. (28.3 per 100,000). Thus, these aforementioned factors are acting as catalyzing factors for market growth at a significant rate. Moreover, the rising product launch and product approval for opioid use disorder drugs, as well as the growing investment in R&D activities are presenting various lucrative opportunities over the forecasting years. However, the complex reimbursement structure and adverse effects of OUD drugs are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Opioid Use Disorder (OUD) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of government policies, along with increasing new product launches in the region. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of patients suffering from opioid dependency, growing awareness amongst the general population regarding OUD, and increasing expenditure on healthcare in the market space.
Major market players included in this report are:
MediciNova
Indivior PLC
Alkermes
Orexo AB
Titan Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
BioDelivery Sciences International Inc.
Viatris Inc. (Mylan N.V.)
Hikma Pharmaceuticals PLC
Camurus
Recent Developments in the Market:
In February 2021, Orexo AB unveiled that the company entered into a collaborative agreement with ApexB.io and Magellan Rx Management in order to do further study on the usage of Modi. This product is a specially designed digital therapeutic for patients with Opioid Use Disorder.
Global Opioid Use Disorder (OUD) Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Route of Administration, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Buprenorphine
Methadone
Naltrexone
By Route of Administration:
Home
Dentistry
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies & Stores
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The rising cases of opioid addiction and related consequences are burgeoning the market demand across the globe. The National Drug Dependence Treatment Centre's (NDDTC) Magnitude of Substance Use in India reported that in February 2019, the prevalence of current opioid use is 2.06%, and approximately 0.55% of Indians are expected to require treatment for opioid use disorders (harmful use and dependence). Also, as per the Centers for Disease Control and Prevention, in 2020, there were nearly 91,799 people died from drug overdoses in the US. Age-adjusted overdose death rates increased from 21.6 per 100,000 in 2019 to 31.1 per 100,000 in 2020. (28.3 per 100,000). Thus, these aforementioned factors are acting as catalyzing factors for market growth at a significant rate. Moreover, the rising product launch and product approval for opioid use disorder drugs, as well as the growing investment in R&D activities are presenting various lucrative opportunities over the forecasting years. However, the complex reimbursement structure and adverse effects of OUD drugs are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Opioid Use Disorder (OUD) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of government policies, along with increasing new product launches in the region. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of patients suffering from opioid dependency, growing awareness amongst the general population regarding OUD, and increasing expenditure on healthcare in the market space.
Major market players included in this report are:
MediciNova
Indivior PLC
Alkermes
Orexo AB
Titan Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
BioDelivery Sciences International Inc.
Viatris Inc. (Mylan N.V.)
Hikma Pharmaceuticals PLC
Camurus
Recent Developments in the Market:
In February 2021, Orexo AB unveiled that the company entered into a collaborative agreement with ApexB.io and Magellan Rx Management in order to do further study on the usage of Modi. This product is a specially designed digital therapeutic for patients with Opioid Use Disorder.
Global Opioid Use Disorder (OUD) Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Route of Administration, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Buprenorphine
Methadone
Naltrexone
By Route of Administration:
Home
Dentistry
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies & Stores
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Opioid Use Disorder (OUD) Market, by Region, 2019-2029 (USD Billion)
1.2.2. Opioid Use Disorder (OUD) Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Opioid Use Disorder (OUD) Market, by Route of Administration, 2019-2029 (USD Billion)
1.2.4. Opioid Use Disorder (OUD) Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPIOID USE DISORDER (OUD) MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPIOID USE DISORDER (OUD) MARKET DYNAMICS
3.1. Opioid Use Disorder (OUD) Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing focus of government & non-government institutions
3.1.1.2. Rising cases of opioid addiction and related consequences
3.1.2. Market Challenges
3.1.2.1. Complex reimbursement structure
3.1.2.2. Adverse effects of OUD drugs
3.1.3. Market Opportunities
3.1.3.1. Rising product launch and product approval for opioid use disorder drugs
3.1.3.2. Growing investment in the R&D activities
CHAPTER 4. GLOBAL OPIOID USE DISORDER (OUD) MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Opioid Use Disorder (OUD) Market by Drug Class, Performance - Potential Analysis
6.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
6.4.1. Buprenorphine
6.4.2. Methadone
6.4.3. Naltrexone
CHAPTER 7. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY ROUTE OF ADMINISTRATION
7.1. Market Snapshot
7.2. Global Opioid Use Disorder (OUD) Market by Route of Administration, Performance - Potential Analysis
7.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
CHAPTER 8. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Opioid Use Disorder (OUD) Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies & Stores
8.4.3. Online Pharmacies
CHAPTER 9. GLOBAL OPIOID USE DISORDER (OUD) MARKET, REGIONAL ANALYSIS
9.1. Opioid Use Disorder (OUD) Market, Regional Market Snapshot
9.2. North America Opioid Use Disorder (OUD) Market
9.2.1. U.S. Opioid Use Disorder (OUD) Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Opioid Use Disorder (OUD) Market
9.3. Europe Opioid Use Disorder (OUD) Market Snapshot
9.3.1. U.K. Opioid Use Disorder (OUD) Market
9.3.2. Germany Opioid Use Disorder (OUD) Market
9.3.3. France Opioid Use Disorder (OUD) Market
9.3.4. Spain Opioid Use Disorder (OUD) Market
9.3.5. Italy Opioid Use Disorder (OUD) Market
9.3.6. Rest of Europe Opioid Use Disorder (OUD) Market
9.4. Asia-Pacific Opioid Use Disorder (OUD) Market Snapshot
9.4.1. China Opioid Use Disorder (OUD) Market
9.4.2. India Opioid Use Disorder (OUD) Market
9.4.3. Japan Opioid Use Disorder (OUD) Market
9.4.4. Australia Opioid Use Disorder (OUD) Market
9.4.5. South Korea Opioid Use Disorder (OUD) Market
9.4.6. Rest of Asia Pacific Opioid Use Disorder (OUD) Market
9.5. Latin America Opioid Use Disorder (OUD) Market Snapshot
9.5.1. Brazil Opioid Use Disorder (OUD) Market
9.5.2. Mexico Opioid Use Disorder (OUD) Market
9.5.3. Rest of Latin America Opioid Use Disorder (OUD) Market
9.6. Rest of The World Opioid Use Disorder (OUD) Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. MediciNova
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Indivior PLC
10.2.3. Alkermes
10.2.4. Orexo AB
10.2.5. Titan Pharmaceuticals, Inc.
10.2.6. Mallinckrodt Pharmaceuticals
10.2.7. BioDelivery Sciences International Inc.
10.2.8. Viatris Inc. (Mylan N.V.)
10.2.9. Hikma Pharmaceuticals PLC
10.2.10. Camurus
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Opioid Use Disorder (OUD) Market, by Region, 2019-2029 (USD Billion)
1.2.2. Opioid Use Disorder (OUD) Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Opioid Use Disorder (OUD) Market, by Route of Administration, 2019-2029 (USD Billion)
1.2.4. Opioid Use Disorder (OUD) Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPIOID USE DISORDER (OUD) MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPIOID USE DISORDER (OUD) MARKET DYNAMICS
3.1. Opioid Use Disorder (OUD) Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing focus of government & non-government institutions
3.1.1.2. Rising cases of opioid addiction and related consequences
3.1.2. Market Challenges
3.1.2.1. Complex reimbursement structure
3.1.2.2. Adverse effects of OUD drugs
3.1.3. Market Opportunities
3.1.3.1. Rising product launch and product approval for opioid use disorder drugs
3.1.3.2. Growing investment in the R&D activities
CHAPTER 4. GLOBAL OPIOID USE DISORDER (OUD) MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Opioid Use Disorder (OUD) Market by Drug Class, Performance - Potential Analysis
6.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
6.4.1. Buprenorphine
6.4.2. Methadone
6.4.3. Naltrexone
CHAPTER 7. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY ROUTE OF ADMINISTRATION
7.1. Market Snapshot
7.2. Global Opioid Use Disorder (OUD) Market by Route of Administration, Performance - Potential Analysis
7.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
CHAPTER 8. GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Opioid Use Disorder (OUD) Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies & Stores
8.4.3. Online Pharmacies
CHAPTER 9. GLOBAL OPIOID USE DISORDER (OUD) MARKET, REGIONAL ANALYSIS
9.1. Opioid Use Disorder (OUD) Market, Regional Market Snapshot
9.2. North America Opioid Use Disorder (OUD) Market
9.2.1. U.S. Opioid Use Disorder (OUD) Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Opioid Use Disorder (OUD) Market
9.3. Europe Opioid Use Disorder (OUD) Market Snapshot
9.3.1. U.K. Opioid Use Disorder (OUD) Market
9.3.2. Germany Opioid Use Disorder (OUD) Market
9.3.3. France Opioid Use Disorder (OUD) Market
9.3.4. Spain Opioid Use Disorder (OUD) Market
9.3.5. Italy Opioid Use Disorder (OUD) Market
9.3.6. Rest of Europe Opioid Use Disorder (OUD) Market
9.4. Asia-Pacific Opioid Use Disorder (OUD) Market Snapshot
9.4.1. China Opioid Use Disorder (OUD) Market
9.4.2. India Opioid Use Disorder (OUD) Market
9.4.3. Japan Opioid Use Disorder (OUD) Market
9.4.4. Australia Opioid Use Disorder (OUD) Market
9.4.5. South Korea Opioid Use Disorder (OUD) Market
9.4.6. Rest of Asia Pacific Opioid Use Disorder (OUD) Market
9.5. Latin America Opioid Use Disorder (OUD) Market Snapshot
9.5.1. Brazil Opioid Use Disorder (OUD) Market
9.5.2. Mexico Opioid Use Disorder (OUD) Market
9.5.3. Rest of Latin America Opioid Use Disorder (OUD) Market
9.6. Rest of The World Opioid Use Disorder (OUD) Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. MediciNova
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Indivior PLC
10.2.3. Alkermes
10.2.4. Orexo AB
10.2.5. Titan Pharmaceuticals, Inc.
10.2.6. Mallinckrodt Pharmaceuticals
10.2.7. BioDelivery Sciences International Inc.
10.2.8. Viatris Inc. (Mylan N.V.)
10.2.9. Hikma Pharmaceuticals PLC
10.2.10. Camurus
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Opioid Use Disorder (OUD) Market, report scope
TABLE 2. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 5. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Opioid Use Disorder (OUD) Market
TABLE 71. List of primary sources, used in the study of global Opioid Use Disorder (OUD) Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Opioid Use Disorder (OUD) Market, report scope
TABLE 2. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 5. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Opioid Use Disorder (OUD) Market
TABLE 71. List of primary sources, used in the study of global Opioid Use Disorder (OUD) Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Opioid Use Disorder (OUD) Market, research methodology
FIG 2. Global Opioid Use Disorder (OUD) Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Opioid Use Disorder (OUD) Market, key trends 2021
FIG 5. Global Opioid Use Disorder (OUD) Market, growth prospects 2022-2029
FIG 6. Global Opioid Use Disorder (OUD) Market, porters 5 force model
FIG 7. Global Opioid Use Disorder (OUD) Market, pest analysis
FIG 8. Global Opioid Use Disorder (OUD) Market, value chain analysis
FIG 9. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Opioid Use Disorder (OUD) Market, regional snapshot 2019 & 2029
FIG 15. North America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 16. Europe Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 19. Global Opioid Use Disorder (OUD) Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Opioid Use Disorder (OUD) Market, research methodology
FIG 2. Global Opioid Use Disorder (OUD) Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Opioid Use Disorder (OUD) Market, key trends 2021
FIG 5. Global Opioid Use Disorder (OUD) Market, growth prospects 2022-2029
FIG 6. Global Opioid Use Disorder (OUD) Market, porters 5 force model
FIG 7. Global Opioid Use Disorder (OUD) Market, pest analysis
FIG 8. Global Opioid Use Disorder (OUD) Market, value chain analysis
FIG 9. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Opioid Use Disorder (OUD) Market, regional snapshot 2019 & 2029
FIG 15. North America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 16. Europe Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
FIG 19. Global Opioid Use Disorder (OUD) Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
